Literature DB >> 28756634

Necrotizing sarcoid granulomatosis: A distinctive form of pulmonary granulomatous disease.

Georgia Karpathiou1, Anna Batistatou2, Panagiotis Boglou3, Dimitrios Stefanou2, Marios E Froudarakis3.   

Abstract

OBJECTIVES: To define the characteristics of necrotizing sarcoid granulomatosis (NGS) a very rare pulmonary disease hardly recognised by pulmonologists and pathologists. DATA SOURCE: PubMed was searched for the term necrotising or necrotizing sarcoid granulomatosis. STUDY SELECTION: All cases reported in the English literature were included.
RESULTS: NGS is presented at all ages (range 8-68 years) with a median age of 42 years old. It shows female (62%) and Caucasian (80%) predominance. The most frequent symptoms are cough, fever, dyspnoea and chest pain. Extra-pulmonary involvement is found in one third of the cases, with ocular being the most common (12.5%). At imaging, multiple nodules (64.75%) or a solitary mass (20.49%) are found accompanied by mediastinal lymphadenopathy at one third of the cases. It can be clinically mistaken for malignancy as it is tumour-like, increases rapidly in size and it is hyperfixating in PET-SCAN. Histologically, NGS is defined by large areas of necrosis, well-formed granulomas and vascularitis.
CONCLUSION: NGS is a disease often confounded clinically with malignancy or with sarcoidosis even histologically when all criteria are not strictly applied. This review provides NGS' characteristics and discusses its differential diagnosis form sarcoidosis, Wegener granulomatosis and tuberculosis.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  Wegener granulomatosis; granulomatosis; lung; necrotizing sarcoid granulomatosis; sarcoidosis

Mesh:

Year:  2017        PMID: 28756634     DOI: 10.1111/crj.12673

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  8 in total

Review 1.  Noninfectious Granulomatous Diseases of the Chest.

Authors:  Muhammad Naeem; David H Ballard; Hamza Jawad; Constantine Raptis; Sanjeev Bhalla
Journal:  Radiographics       Date:  2020-06-05       Impact factor: 5.333

2.  A rare presentation of necrotizing sarcoidosis.

Authors:  Nirali Sheth; Umaima Dhamrah; Branden Ireifej; David Song; Penpa Bhuti; Jagbir Singh; Henry Fan; Sibghatallah Ummar; Vikash Jaiswal; Nishan Babu Pokhrel
Journal:  Respirol Case Rep       Date:  2022-05-10

3.  Pulmonary sarcoidosis with arterial involvement.

Authors:  Adriane Souza da Paz; João Carlos Coelho; Bartira Melo; Ana Luísa Pedreira; Mittermayer Barreto Santiago
Journal:  Autops Case Rep       Date:  2021-07-08

4.  Necrotising sarcoid granulomatosis. A rare granulomatous disease.

Authors:  Martina Doubková; Jitka Hausnerová; Ondřej Výška; Svatopluk Richter; Zdeněk Merta
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

Review 5.  Clinical Features, Histopathology and Differential Diagnosis of Sarcoidosis.

Authors:  Claudio Tana; Iginio Donatiello; Alessandro Caputo; Marco Tana; Teresa Naccarelli; Cesare Mantini; Fabrizio Ricci; Andrea Ticinesi; Tiziana Meschi; Francesco Cipollone; Maria Adele Giamberardino
Journal:  Cells       Date:  2021-12-26       Impact factor: 6.600

6.  Acute Kidney Injury Secondary to Necrotizing Sarcoid Granulomatosis.

Authors:  Varun Mamidi; Manikantan Shekar; Jaiju James Chakola; Vamsi Krishna Makkena; Jayakumar Matcha
Journal:  Case Rep Nephrol       Date:  2019-11-05

7.  Investigation of Granulomatous Inflammations in Terms of Tuberculosis Diagnosis: A 5-Year Multi-center Laboratory Study.

Authors:  Derya Öztomurcuk; Özlem Terzi; Canan Demirci; Zeki Kılıçaslan
Journal:  Turk Thorac J       Date:  2022-01

8.  A Solitary Necrotizing Sarcoid Granulomatosis-like Pulmonary Lesion Possibly Associated with Propionibacterium acnes and Mycobacterium avium.

Authors:  Keigo Murakami; Shuko Hata; Naoya Ishibashi; Motoki Kubota; Yoshinobu Eishi; Keisuke Uchida; Toshiharu Tabata; Yasuhiro Nakamura; Kazuhiro Murakami
Journal:  Intern Med       Date:  2021-06-12       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.